GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

51

Engineered T-Cell Therapy and HCC - J of Hepatology. Jan 26

Engineered T-cell therapy is a precision immunotherapy approach designed to treat cancer by modifying a patient's T cells to enhance their ability to target and destroy cancer cells....

52

Serum N-Glycomics analysis and HBV - Hepatology Jan.2026

Serum N-glycomics analysis refers to the study of N-linked glycans (complex sugar molecules attached to proteins) present in serum. This analytical approach focuses on profiling and identifying specific...

53

HCC risk in PSC (Hepatology Jan. 26)

Introduction: Primary sclerosing cholangitis (PSC) is a chronic liver disease that can lead to complications, including hepatocellular carcinoma (HCC). However, the actual risk of developing HCC in PSC...

54

MASLD and HCC

Metabolic dysfunction–associated steatotic liver disease (MASLD) and hepatocellular carcinoma (HCC) are closely interconnected, with MASLD emerging as a significant risk factor and contributor to the development of HCC....

55

AHCTF1 Promotes Tumor Progression in Hepatocellular Carcinoma

Yes, AHCTF1 plays a significant role in promoting tumor progression in hepatocellular carcinoma (HCC). Below is a detailed explanation of how AHCTF1 contributes to HCC progression based on...

56

Liver Decompensation With Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

The study on atezolizumab–bevacizumab treatment for advanced or unresectable hepatocellular carcinoma (HCC) provides valuable insights into liver decompensation as a key clinical consideration. Below is a detailed analysis...

57

Perioperative nursing coordination and complication management in Yttrium-90 radioactive microsphere therapy for hepatocellular carcinoma

Perioperative nursing coordination and complication management in Yttrium-90 (Y-90) radioactive microsphere therapy for hepatocellular carcinoma (HCC) is a highly structured and multidisciplinary process aimed at ensuring patient safety,...

58

HCC surveillance: minimum standards

Hepatocellular carcinoma (HCC) surveillance is crucial for early detection and improved survival rates, particularly in at-risk populations such as those with chronic liver disease or cirrhosis. To ensure...

59

Therapeutic targets of SphK1 and SphK2 in hepatocellular carcinoma

SphK1 and SphK2 are critical therapeutic targets in hepatocellular carcinoma (HCC) due to their involvement in tumor progression, survival, and resistance mechanisms. Below is a detailed overview of...

60

Key Differences in Y90 vs. SBRT Dosing in HCC

Role of Radiotherapy in HCC (Hepatocellular Carcinoma): Radiotherapy plays a critical role in treating HCC, particularly for patients who are not candidates for surgery or liver transplantation. It...

Previous
1234567
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer